Brief: Integra LifeSciences Reports Fourth Quarter 2022 Financial Results

Integra LifeSciences Holdings

22/02/2023 11:04

Feb 22 (Reuters) - Integra Lifesciences Holdings Corp
 IART.O :
    * INTEGRA LIFESCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR
2022
FINANCIAL RESULTS AND PROVIDES 2023 FINANCIAL GUIDANCE
    * QTRLY ADJUSTED EARNINGS PER DILUTED SHARE WERE $0.94
    * QTRLY GAAP EARNINGS PER DILUTED SHARE WERE $0.63
    * FOR FULL-YEAR 2023, COMPANY EXPECTS REVENUES TO BE IN A
RANGE OF
$1,602 MILLION TO $1,620 MILLION
    * FY ADJUSTED EARNINGS PER DILUTED SHARE ARE EXPECTED TO BE
BETWEEN $3.43 AND $3.51.
    * FOR Q1 2023, COMPANY EXPECTS REPORTED REVENUES IN RANGE OF
$370
MILLION TO $376 MILLION
    * Q1 ADJUSTED EARNINGS PER DILUTED SHARE ARE EXPECTED TO BE
IN A
RANGE OF $0.72 TO $0.76.
    * Q4 EARNINGS PER SHARE VIEW $0.90, REVENUE VIEW $398.0
MILLION --
REFINITIV IBES DATA
    * Q1 EARNINGS PER SHARE VIEW $0.79, REVENUE VIEW $381.7
MILLION --
REFINITIV IBES DATA
    * FY2023 EARNINGS PER SHARE VIEW $3.52, REVENUE VIEW $1.62
BILLION
-- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX1N41tG 
Further company coverage:  IART.O 
 ((Reuters.Briefs@thomsonreuters.com;))